Role of extracellular calcitonin gene-related peptide in spinal cord mechanisms of cancer-induced bone pain

Rikke R. Hansen, Valentina Vacca, Thomas Pitcher, Anna K. Clark, Marzia Malcangio

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Severe pain is a common and debilitating complication of metastatic bone cancer. Current analgesics provide insufficient pain relief and often lead to significant adverse effects. In models of cancer-induced bone pain, pathological sprouting of sensory fibers at the tumor-bone interface occurs concomitantly with reactive astrocytosis in the dorsal horn of the spinal cord. We observed that calcitonin gene-related peptide (CGRP)-fiber sprouting in the bone was associated with an increase in CGRP content in sensory neuron cell bodies in the dorsal root ganglia (DRG) and increased basal and activity-evoked release of CGRP from their central terminals in the dorsal horn. Intrathecal administration of a peptide antagonist (α-CGRP8-37) attenuated referred allodynia in the hind paw ipsilateral to bone cancer. CGRP receptor components (CLR and RAMP1) were up-regulated in dorsal horn neurons and expressed by reactive astrocytes. In primary cultures of astrocytes, CGRP incubation led to a concentration-dependent increase of forskolin-induced cAMP production, which was attenuated by pretreatment with CGRP8-37. Furthermore, CGRP induced ATP release in astrocytes, which was inhibited by CGRP8-37. We suggest that the peripheral increase in CGRP content observed in cancer-induced bone pain is mirrored by a central increase in the extracellular levels of CGRP. This increase in CGRP not only may facilitate glutamate-driven neuronal nociceptive signaling but also act on astrocytic CGRP receptors and lead to release of ATP.

Original languageEnglish
Pages (from-to)666-676
Number of pages11
JournalPain
Volume157
Issue number3
DOIs
Publication statusPublished - Mar 1 2016

Fingerprint

Bone Neoplasms
Calcitonin Gene-Related Peptide
Spinal Cord
Pain
Astrocytes
Calcitonin Gene-Related Peptide Receptors
Adenosine Triphosphate
Posterior Horn Cells
Bone and Bones
Gliosis
Hyperalgesia
Spinal Ganglia
Sensory Receptor Cells
Colforsin
Analgesics
Glutamic Acid
Peptides

Keywords

  • Astrocyte
  • Calcitonin gene-related peptide
  • Cancer-induced bone pain

ASJC Scopus subject areas

  • Clinical Neurology
  • Anesthesiology and Pain Medicine
  • Neurology
  • Pharmacology

Cite this

Role of extracellular calcitonin gene-related peptide in spinal cord mechanisms of cancer-induced bone pain. / Hansen, Rikke R.; Vacca, Valentina; Pitcher, Thomas; Clark, Anna K.; Malcangio, Marzia.

In: Pain, Vol. 157, No. 3, 01.03.2016, p. 666-676.

Research output: Contribution to journalArticle

Hansen, Rikke R. ; Vacca, Valentina ; Pitcher, Thomas ; Clark, Anna K. ; Malcangio, Marzia. / Role of extracellular calcitonin gene-related peptide in spinal cord mechanisms of cancer-induced bone pain. In: Pain. 2016 ; Vol. 157, No. 3. pp. 666-676.
@article{05a340894c754c87a05b3f394018dd8c,
title = "Role of extracellular calcitonin gene-related peptide in spinal cord mechanisms of cancer-induced bone pain",
abstract = "Severe pain is a common and debilitating complication of metastatic bone cancer. Current analgesics provide insufficient pain relief and often lead to significant adverse effects. In models of cancer-induced bone pain, pathological sprouting of sensory fibers at the tumor-bone interface occurs concomitantly with reactive astrocytosis in the dorsal horn of the spinal cord. We observed that calcitonin gene-related peptide (CGRP)-fiber sprouting in the bone was associated with an increase in CGRP content in sensory neuron cell bodies in the dorsal root ganglia (DRG) and increased basal and activity-evoked release of CGRP from their central terminals in the dorsal horn. Intrathecal administration of a peptide antagonist (α-CGRP8-37) attenuated referred allodynia in the hind paw ipsilateral to bone cancer. CGRP receptor components (CLR and RAMP1) were up-regulated in dorsal horn neurons and expressed by reactive astrocytes. In primary cultures of astrocytes, CGRP incubation led to a concentration-dependent increase of forskolin-induced cAMP production, which was attenuated by pretreatment with CGRP8-37. Furthermore, CGRP induced ATP release in astrocytes, which was inhibited by CGRP8-37. We suggest that the peripheral increase in CGRP content observed in cancer-induced bone pain is mirrored by a central increase in the extracellular levels of CGRP. This increase in CGRP not only may facilitate glutamate-driven neuronal nociceptive signaling but also act on astrocytic CGRP receptors and lead to release of ATP.",
keywords = "Astrocyte, Calcitonin gene-related peptide, Cancer-induced bone pain",
author = "Hansen, {Rikke R.} and Valentina Vacca and Thomas Pitcher and Clark, {Anna K.} and Marzia Malcangio",
year = "2016",
month = "3",
day = "1",
doi = "10.1097/j.pain.0000000000000416",
language = "English",
volume = "157",
pages = "666--676",
journal = "Pain",
issn = "0304-3959",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - Role of extracellular calcitonin gene-related peptide in spinal cord mechanisms of cancer-induced bone pain

AU - Hansen, Rikke R.

AU - Vacca, Valentina

AU - Pitcher, Thomas

AU - Clark, Anna K.

AU - Malcangio, Marzia

PY - 2016/3/1

Y1 - 2016/3/1

N2 - Severe pain is a common and debilitating complication of metastatic bone cancer. Current analgesics provide insufficient pain relief and often lead to significant adverse effects. In models of cancer-induced bone pain, pathological sprouting of sensory fibers at the tumor-bone interface occurs concomitantly with reactive astrocytosis in the dorsal horn of the spinal cord. We observed that calcitonin gene-related peptide (CGRP)-fiber sprouting in the bone was associated with an increase in CGRP content in sensory neuron cell bodies in the dorsal root ganglia (DRG) and increased basal and activity-evoked release of CGRP from their central terminals in the dorsal horn. Intrathecal administration of a peptide antagonist (α-CGRP8-37) attenuated referred allodynia in the hind paw ipsilateral to bone cancer. CGRP receptor components (CLR and RAMP1) were up-regulated in dorsal horn neurons and expressed by reactive astrocytes. In primary cultures of astrocytes, CGRP incubation led to a concentration-dependent increase of forskolin-induced cAMP production, which was attenuated by pretreatment with CGRP8-37. Furthermore, CGRP induced ATP release in astrocytes, which was inhibited by CGRP8-37. We suggest that the peripheral increase in CGRP content observed in cancer-induced bone pain is mirrored by a central increase in the extracellular levels of CGRP. This increase in CGRP not only may facilitate glutamate-driven neuronal nociceptive signaling but also act on astrocytic CGRP receptors and lead to release of ATP.

AB - Severe pain is a common and debilitating complication of metastatic bone cancer. Current analgesics provide insufficient pain relief and often lead to significant adverse effects. In models of cancer-induced bone pain, pathological sprouting of sensory fibers at the tumor-bone interface occurs concomitantly with reactive astrocytosis in the dorsal horn of the spinal cord. We observed that calcitonin gene-related peptide (CGRP)-fiber sprouting in the bone was associated with an increase in CGRP content in sensory neuron cell bodies in the dorsal root ganglia (DRG) and increased basal and activity-evoked release of CGRP from their central terminals in the dorsal horn. Intrathecal administration of a peptide antagonist (α-CGRP8-37) attenuated referred allodynia in the hind paw ipsilateral to bone cancer. CGRP receptor components (CLR and RAMP1) were up-regulated in dorsal horn neurons and expressed by reactive astrocytes. In primary cultures of astrocytes, CGRP incubation led to a concentration-dependent increase of forskolin-induced cAMP production, which was attenuated by pretreatment with CGRP8-37. Furthermore, CGRP induced ATP release in astrocytes, which was inhibited by CGRP8-37. We suggest that the peripheral increase in CGRP content observed in cancer-induced bone pain is mirrored by a central increase in the extracellular levels of CGRP. This increase in CGRP not only may facilitate glutamate-driven neuronal nociceptive signaling but also act on astrocytic CGRP receptors and lead to release of ATP.

KW - Astrocyte

KW - Calcitonin gene-related peptide

KW - Cancer-induced bone pain

UR - http://www.scopus.com/inward/record.url?scp=84962088922&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84962088922&partnerID=8YFLogxK

U2 - 10.1097/j.pain.0000000000000416

DO - 10.1097/j.pain.0000000000000416

M3 - Article

AN - SCOPUS:84962088922

VL - 157

SP - 666

EP - 676

JO - Pain

JF - Pain

SN - 0304-3959

IS - 3

ER -